ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Gainers & Losers: IIFL Finance, Dr Reddy’s among 7 stocks that moved most on Thursday
Indian markets snapped a three-day losing streak as Nifty and Sensex closed higher. Stocks like Gokaldas Exports, CreditAccess Grameen and Amagi gained, while IIFL Finance and PNB Housing fell sharply despite earnings updates.
Announcement as on 22 January 2026

Dr Reddy's Laboratories Q3 Results: Profit falls 14% YoY to Rs 1,210 crore, revenue up 4%
Dr Reddy’s Laboratories reported a 14% YoY drop in Q3 net profit to Rs 1,210 crore, even as revenue rose 4% to Rs 8,727 crore. Lower margins and a 12% decline in North America sales weighed on performance, partly offset by strong growth in India, Europe an
Announcement as on 21 January 2026

Dr Reddy's Q3 preview: PAT may fall 22% YoY as US pressure to weigh on earnings
Dr Reddy's Laboratories anticipates a subdued performance for the December quarter. Pressure from its United States business is expected to offset steady growth in India and Europe. Analysts predict a decline in revenue and profit after tax. The US market
Announcement as on 20 January 2026

Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug
Dr. Reddy's Laboratories has secured an exclusive licensing agreement with Immutep to manufacture, develop, and distribute the Australian company's cancer therapy, eftilagimod alfa. This significant deal, valued at up to 0 million, grants Dr. Reddy's di
Announcement as on 08 December 2025

India weight-loss market reset? In setback for Novo Nordisk, Dr Reddy's Lab allowed to make semaglutide
The order follows the court’s view that Novo Nordisk’s patent appears prima facie invalid -- a finding that could reshape competitive dynamics in a market valued at around Rs 850 crore.
Announcement as on 03 December 2025

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 13.89
  • 12Day Average: 13.7
  • 20Day Average: 13.5
  • 50Day Average: 13.79
  • 100Day Average: 13.95
  • 150Day Average: 14.08
  • 200Day Average: 14.22

RDY Indicators & signals

Indicator MACD (12,26,9)

13.72, 13.68, -0.06
Indicator MACD is in positive zone

Indicator ADX (14)

17.65, 33.33, 23.33
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Fri Feb 2026 14.08 13.84 to 14.14 0.79% 1.34 times
05 Thu Feb 2026 13.97 13.87 to 14.11 -0.21% 1.3 times
04 Wed Feb 2026 14.00 13.75 to 14.06 1.38% 1.17 times
03 Tue Feb 2026 13.81 13.65 to 13.88 1.47% 1.68 times
02 Mon Feb 2026 13.61 12.95 to 13.62 1.42% 1.36 times
30 Fri Jan 2026 13.42 13.26 to 13.47 1.13% 0.76 times
29 Thu Jan 2026 13.27 13.13 to 13.31 -0.38% 0.92 times
28 Wed Jan 2026 13.32 13.31 to 13.45 -2.84% 0.52 times
27 Tue Jan 2026 13.71 13.64 to 13.80 -0.51% 0.74 times
26 Mon Jan 2026 13.78 13.59 to 13.85 0.73% 0.69 times
23 Fri Jan 2026 13.68 13.52 to 13.80 -0.22% 0.85 times
22 Thu Jan 2026 13.71 13.36 to 13.95 3.24% 1.9 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

 

Back to top